Help your eligible patients save on LACRISERT ®

Eligible patients pay NO MORE THAN $35* CO-PAY

Most eligible commercially insured patients pay no more than $35 co-pay for 1st prescription and eligible refills. Exclusively at Walgreens and other participating independent pharmacies.
Discounted pricing is also available for eligible uninsured patients.*

Ensure your patients activate their coupon

ACTIVATE: To activate the print coupon, call 1-866-693-4880.
To activate the online web coupon, visit
www.bauschaccessprogram.com and follow the instructions.
Size
60 VIALS
Eligible Commercially Insured*
$35 CO-PAY
Eligible Uninsured*
$75 CO-PAY
Eligible Fills*
6
*Terms and conditions apply. Please see www.bauschaccessprogram.com for eligible criteria and terms and conditions.
If you have any questions regarding your eligibility or benefits, please call 1-866-693-4880.

Indications and Usage

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

  • LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.
  • Instructions for inserting and removing LACRISERT should be carefully followed.
  • If improperly placed, LACRISERT may result in corneal abrasion. Because LACRISERT may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery.
  • The following adverse reactions have been reported, but were in most instances mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.

To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.FDA.gov/medwatch.

Please see full Prescribing Information for LACRISERT® (hydroxypropyl cellulose ophthalmic insert).

Indications and Usage

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is indicated in patients with moderate to severe dry eye syndromes, including keratoconjunctivitis sicca. LACRISERT is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.

Important Safety Information

  • LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.

Important Safety Information

LACRISERT® (hydroxypropyl cellulose ophthalmic insert) is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose.